clinical-drug-testing-230x195

Solving the challenges of clinical drug testing

In pharmacokinetic studies, bioanalysis method validation is crucial to minimizing random error and systematic bias, which ensures quality of analytical results. Bioanalytical method validation is a controlled procedure that comprises all the vital steps to establish that a certain method is capable of producing accurate, dependable and reproducible results that are appropriate for a specific analytical application.

  • Learn more about our bioanalysis preclinical & clinical workflows.
  • Get access to a variety of resources, such as webinars, applications, and articles.
  • We can help you provide reliable, accurate, and precise results for drug testing & data management.

Featured resources

Learn about new sample preparation technologies for improved peptide quantitation to simplify bioanalysis of proteins.

HRAM, the next generation mass spectrometry for quantitative bioanalysis. High-throughput methods for quantitation of biotherapeutics by both intact protein and proteolytic peptides.


Raloxifene, a non-steroidal selective estrogen receptor regulator, is currently applied to both the prevention and treatment of postmenopausal osteoporosis. It acts as an estrogen agonist in bone and liver, and in this way, increases bone mineral density and decreases levels of LDL-cholesterol.


Featured videos

Covance - The power of HRAM MS for Bioanalysis of Complex Therapeutics
Troy Voelker of Covance discusses why they chose the Q Exactive systems for HRAM MS bioanalysis of oligonucleotides and other novel therapeutics
Video Player is loading.
Current Time 0:00
Duration 4:41
Loaded: 0%
Stream Type LIVE
Remaining Time 4:41
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected
      1. Now Playing
        Up NextCovance - The power of HRAM MS for Bioanalysis of Complex Therapeutics

        Troy Voelker of Covance discusses why they chose the Q Exactive systems for HRAM MS bioanalysis of oligonucleotides and other novel therapeutics

      2. Now Playing
        Up NextPRA Health Sciences - Watson LIMS: The Hub of Bioanalytical Compliance

        Chad Briscoe of PRA Health Sciences discusses why they chose Watson LIMS to overcome data challenges in regulated bioanalysis

      3. Now Playing
        Up NextAlturas Analytics - Stand-Out Bioanalysis Capabilities with GC-MS

        Ann Hoffmann of Alturas Analytics discusses why they chose the TSQ Quantum XLS GC-MS/MS system to offer non-standard bioanalytical services


    Share